Objective To evaluate the performance of complement depend micro-lymphocytotoxicity assay (CDMA) for the detection of human leucocyte antigen-B27 (HLA-B27).
The first part of Dr Schrepfer's approach is therefore to prevent the production of HLA proteins in laboratory-grown beta cells destined for transplant.